Background/Aims: Praeruptorins, a seselin-type coumarin, possess anti-inflammatory and antitumor promoting properties. However, molecular mechanisms through which Praeruptorin-B (Pra-B) exerts an antimetastatic effect on cervical cancer cells remain unclear. Methods: Cell viability was examined using the MTT assay, whereas cell migration and invasion were examined using the Boyden chamber assay. Western blotting and RT-PCR were performed to investigate the inhibitory effect of Pra-B on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced matrix metalloproteinase-2/-9 (MMP-2/-9) expression in HeLa cells. The findings of the luciferase assay confirmed the inhibitory effect of Pra-B on TPA-induced transcriptional activity of MMP-2/-9 in HeLa cells. Results: Pra-B inhibited TPA-induced metastatic ability of human cervical cancer cells without any significant toxicity. Pra-B suppressed TPA-induced mRNA and protein expression and transcriptional activity of MMP-2/-9 in HeLa cells. Furthermore, Pra-B inhibited AKT phosphorylation but did not affect the MAPK pathway. Cotreatment of HeLa cells with TPA plus Pra-B or LY294002 (a PI3K inhibitor) reduced cell invasion and MMP-2/-9 expression
Introduction
Cervical cancer is a common malignancy in women. Because of lack of access to preventive human papillomavirus vaccines, screening, and advanced medical equipment for therapy, the incidence of cervical cancer in middle-and low-developing countries has been increasing every year [1] . The metastasis of cervical carcinoma to other organ, such as lymph nodes, are decisive factors contributing to poor outcomes in cervical cancer patients [2] . Therefore, in addition to surgical and chemotherapeutic treatment, inhibiting metastasis may be an assisted treatment for patients with cervical cancer.
Peucedanum praeruptorum Dunn (also called Qianhu in Chinese) is a well-known herb in Chinese medicine. It has been widely biological activities, such as anti-inflammatory [3, 4] , anti-hypertensive [5] , and anti-tumor [6, 7] activities. Phytochemical research indicated that praeruptorins, a seselin-type coumarin, are one of the main components present in the roots of Peucedanum praeruptorum Dunn, and praeruptorins can be divided into five species: A, B, C, D and E. A recent study reported that praeruptorin A inhibited the p38/AKT/c-Fos/ NAFTc1 pathway and osteoclasts, suggesting that praeruptorin A exerts a protective effect on osteoporosis [8] . The expression level of the UGT1A1 gene was decreased in patients, resulting in a high risk of toxic side effects caused by the anticancer drug irinotecan (CPT-11) [9] . However, another study indicated that praeruptorins could increase UGT1A1 gene expression and may be used as anticancer adjuvants in hepatocellular carcinoma [10] . In addition, praeruptorin C induced apoptosis of HL-60 cells by activating Bax protein and reducing mitochondrial membrane potential [11] . Another study demonstrated that praeruptorins enhanced the sensitivity of anticancer drugs, namely doxorubicin, paclitaxel, puromycin, and vincristine, in cancer cells [12] . Recently, we found that praeruptorin A could inhibit the proliferation and metastasis of cervical cancer cells [13] . However, the anti-tumor effect of Praeruptorin-B (Pra-B) on cervical cancer remains unclear.
The nuclear factor NF-κB is transcription factor which plays a crucial role in viral replication, inflammation, and tumorigenesis [14, 15] . Members of the NF-κB family share structural homology with the oncoprotein v-Rel; thus, they are called NF-κB/Rel proteins. In mammals, NF-κB consists of five subunits: RelB, RelA (p65), NF-κB1 (p50), c-Rel and NF-κB2 (p52). These five subunits associate with each other and form homodimers or heterodimers, which are essential for their activation, translocation to the nucleus, and cellular processes regulated by responsive genes [16] . Activation of NF-κB by various stimuli such as UV radiation, cellular ROS, cytokines, growth factors, and bacteria [17] . The NF-κB signaling pathway is activated by two parallel signaling pathways, namely the classical (canonical) pathway and the alternative (noncanonical) pathway [18] . In the classical pathway, p65 and p50 proteins are bound and inhibited by IκB proteins. When these stimuli activate the IκB kinase (IκK) complex, which phosphorylates IκB proteins, the phosphorylation of IκB leads to its ubiquitination and proteasomal degradation. At this point, activated p65 and p50 heterodimers enter the nucleus to promote target gene transcription [19] . The alternative NF-κB pathway is mediated through the activation of the RelB/p52 NF-κB complex, and deregulated noncanonical NF-κB signaling has been associated with lymphoid malignancies [20, 21] . Nicotine could accelerate HeLa cell migration, activate PI3K/Akt and NF-κB expression, and increase vimentin expression [16, 22] . Toll-like receptor-4 was overexpressed in cervical carcinoma and was positively correlated with NF-κB, suggesting that NF-κB plays a crucial role in the occurrence and development of cervical carcinoma [23] . In addition, NF-κB has been reported to mediate matrix metalloproteinases (MMPs) for regulating metastasis in many cancer cells [24] [25] [26] . In the present study, we found that Pra-B inhibited TPA-induced phosphorylation of AKT and disrupted the nuclear translocation of NF-κB to inhibit the expression of MMP-2/-9, thereby suppressing the migration and invasion of human cervical cancer cells. The findings of this purpose provide insights into the potential of Pra-B to inhibit the metastasis of cervical cancer cells by targeting AKT and the NF-κB pathway.
Materials and Methods
Reagent Praeruptorin (Pra-B) was purchased from ChemFaces (Wuham, China). p-AKT, AKT, ERK, p-p38, p38, p-JNK, JNK, p65, p50, lamin B, α-tubulin, and β-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). LY294002 (a PI3K inhibitor) was obtained from Calbiochem (San Diego, CA, USA). MMP-9 and MMP-2 antibodies were purchased from Abcam (Cambridge, UK). MTT was purchased from Sigma (St. Louis, MO, USA). All stock solutions were placed in dark microcentrifuge tubes and stored at -20°C until use.
Cell culture
The HeLa cell line was obtained from the Bioresource Collection and Research Center, Food Industry Research and Development Institute (Hsinchu, Taiwan). The SiHa cell line was obtained from the American Type Culture Collection (Rockville, MD, USA). The culture medium used in experiments was Dulbecco's modified Eagle's medium (Gibco-Invitrogen Corporation, Carlsbad, CA, USA) containing 10% FBS and 1% antibiotics (10, 000 U/ml of penicillin and 10 μg/ml of streptomycin). Cells were maintained in a humidified atmosphere of 5% CO 2 at 37°C.
Cell viability assay
Cell growth was assessed using the MTT assay [27] . In brief, SiHa and HeLa cells (4 × 10 4 cells/well) were seeded in 24-well culture plates. The cells were treated with different concentrations of Pra-B (0~60 μM), TPA (50 ng/ml), or Pra-B in the absence or presence of TPA (50 ng/ml) for 24 h. The medium was removed, and incubated with MTT (5 mg/ml) at 37°C for 4 h. Subsequently, added the isopropanol and detected at a wavelength of 570 nm by using an ELISA reader.
Migration and invasion assay
Migration and invasion activities were assessed using a chamber transwell assay in which membrane filter inserts with 8-μm pores (Corning Incorporated Life Sciences, Tewksbury, MA, USA) were used. HeLa cells were treated with different concentrations of Pra-B in the with or without of TPA (50 ng/ml) for 24 h. Subsequently, HeLa (3 × 10 4 /well) cells were resuspended in 50 μl of serum-free DMEM medium and added to the upper chamber. Fresh DMEM medium (35 μl) was added into the lower chamber. Invasion assay was performed with filter inserts were coated with Matrigel (BD Biosciences, Billerica, MA, USA). After incubation at 37°C for 18-24 h, the cells that migrated to the lower side of the filter were fixed with methanol immediately and then stained with 0.5% crystal violet. Cell migration and invasion were determined by counting cells on the filter at a magnification of 100×.
Immunoblotting
Immunoblotting methods used in this study were the same as those described previously [13] . Cells were washed with cold PBS and homogenized in lysis buffer and centrifugation at 13000 ×g for 30 min at 4°C. Equal amounts of samples were run on 10% SDS-PAGE and subsequently transferred onto a polyvinylidene difluoride (PVDF) membrane. The membrane was blocked for 2 h with 5% nonfat dry milk buffer. After blocking, the membrane was incubated with primary antibodies overnight at 4°C, the membrane was incubated with horseradish peroxidase (HRP) secondary antibody for 2 h at room temperature. The reaction was visualized and detected using a Luminescent Image Analyzer LAS-4000 mini. 
RT-PCR assay
Total RNA was extracted from the cells using TRIzol® (Thermo Fisher Scientific, Waltham, MA, USA) according to manufacturer's instructions. RNA concentrations were measured using a full-spectrum spectrophotometer (HITACHI, Tokyo, Japan), and 500 ng of total RNA was used. RT-PCR was performed using the GoTaq® 1-Step RT-qPCR System (Promega, Madison, Wisconsin, USA). The following primers were used: MMP-2: 5′-TGGCAAGTACGGCTTCTGTC-3′ and 5′-TTCTTGTCGCGGTCGTAGTC-3′; MMP-9: 5′-ACGACGTCTTCCAGTACCGA-3′ and 5′-TCATAGGTCACGTAGCCCAC-3′; and glyceraldehyde 3-phosphate dehydrogenase (GAPDH): 5′-CATCATCCCTGCCTCTACTG-3′ and 5′-GCCTGCTTCACCACCTTC-3′ (Mission Biotech, Taipei, Taiwan).
MMP-2/-9 promoter-driven luciferase assays
HeLa cells (4 × 10 4 cells/well) were seeded in 24-well culture plates. After 24 h of incubation, pGL3-basic (vector) and target gene promoter plasmid (MMP-2/-9) were cotransfected with a β-galactosidase expression vector (pCH110) into the cells by using Turbofect (Fermentas, Carlsbad, CA) according to manufacturer's instructions. After 24 h of transfection, the cells were treated with different concentrations of Pra-B in the with or without of TPA (50 ng/ml) for 24 h. Cell lysates were harvested and assayed using the luciferase and β-galactosidase enzyme assay system (Promega). Luciferase activity was normalized to β-galactosidase expression as an internal control.
Statistical analysis
Differences between data were calculated for significance using GraphPad Prism4 (San Diego, CA). Student's t test or one-way analysis of variance analysis using Tukey's multiple comparison test. P value less than 0.05 or 0.01 was representing statistically significant. All experiments were repeated three times (n = 3), and values are expressed as the mean ± SD.
Results

Effect of Pra-B on the viability of HeLa and SiHa cells
The chemical structure of Praeruptorin (Pra-B) is shown in Fig. 1A . SiHa and HeLa cells were treated with different concentrations of Pra-B (0, 5, 10, 20, 40 and 60 μM) for 24 h, and toxicity was measured using the MTT assay. Our results demonstrated nonsignificant toxicity in HeLa and SiHa cells treated with Pra-B at concentrations between 0 and 20 µM for 24 h, high cytotoxicity at 40 and 60 µM concentrations was observed in both cells (Fig. 1B) . The nontoxic concentration (0~20 µM) of Pra-B was used in subsequent experiments. We did not observe any significant change in cell viability after treatment with Pra-B (10 and 20 μM) in the absence or presence of TPA (50 ng/ml) for 24 h (Fig. 1C) . Cell lysates were analyzed through Western blotting with anti-MMP-2/-9 antibody and β-actin as a loading control. (B) Total RNA was collected, MMP-2/-9 mRNA levels were analyzed through RT-PCR, and GAPDH was used as an internal control. (C) MMP-2/-9 promoter activity levels were measured using the luciferase assay. The values shown are the mean ± SE. **P<0.01 compared with untreated cells. #P<0.01 compared with TPA alone.
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Pra-B inhibits TPA-induced migration and invasion abilities of HeLa and SiHa cells
To further determine the role of Pra-B in TPA-induced cell migration and invasion, we performed cell migration and Matrigel-based invasion assays. As shown in Fig. 2 , compared with untreated control cells, TPA treatment increased the migration and invasion abilities of SiHa and HeLa cells by approximately 3.5-fold. TPA-induced cell migration significantly decreased in a dose-dependent manner after treatment with Pra-B (10 or 20 μM) in HeLa ( Fig. 2A) and SiHa cells (Fig. 2B) . Similar results with Matrigel-based invasion assay ( Fig. 2A, 2B) . The results indicated that Pra-B effectively prevented TPAinduced migration and invasion in cervical cancer cells.
Pra-B inhibits TPA-induced protein and mRNA levels and transcriptional activity of MMP-2/-9 in cervical cancer cells
MMP-2/-9 plays critical roles in tumor invasion and metastasis [28, 29] . The results of Western blotting and RT-PCR showed that Pra-B significantly reduced the TPA-induced protein (Fig. 3A) and mRNA (Fig. 3B ) levels of MMP-2/-9 in HeLa cells. To determine whether Pra-B regulates the transcriptional activity of MMP-2/-9, transient transfection was performed using the human MMP-2/-9 luciferase promoter plasmid. We found that Pra-B significantly inhibited the TPA-induced transcriptional activity of MMP-2/-9 in HeLa cells (Fig. 3C) . These results indicated that Pra-B suppressed the TPA-induced migration and invasion abilities of HeLa cells through the expression of MMP-2/-9.
Pra-B inhibits TPA-induced AKT phosphorylation
To examine the inhibitory effect of Pra-B on TPA-induced AKT and MAPK expression in HeLa cells. The results revealed that the treatment of HeLa cells with TPA significantly increased the phosphorylation of AKT, ERK1/2, JNK1/2, and p38. However, Pra-B reduced only the TPA-induced phosphorylation of AKT but not that of ERK1/2, JNK1/2, and p38 (Fig.  4) .
Pra-B inhibits TPA-induced cell migration, invasion, and MMP-2/-9 expression through AKT phosphorylation
We investigated mechanisms through which Pra-B inhibited TPA-induced migration and invasion through AKT expression. HeLa cells were pretreated with LY294002 (a PI3K inhibitor) for 2 h and then treated with Pra-B (20 mM) and TPA (50 ng/ml) for 22 h. TPA significantly enhanced AKT phosphorylation and MMP-2/-9 expression in HeLa cells; this effect was blocked by Pra-B combined with LY294002 (Fig. 5A) . Pra-B combined with LY294002 exerted a significant inhibitory effect on TPA-induced migration and invasion in HeLa cells (Fig. 5B) . In addition, the results of the luciferase assay showed that Pra-B combined with LY294002 significantly inhibited TPA-induced promoter activities of MMP-2/-9 (Fig. 5C ). These results suggested that Pra-B inhibited cell migration and invasion through TPA-induced activation of the AKT signaling pathway mediated by MMP-2/-9 expression.
Pra-B inhibits TPA-induced cells migration and invasion through the NF-κB signaling pathway
The migration and invasion of human cervical cancer cells were inhibited by blocking the AKT/NF-κB signaling pathway [30, 31] . The NF-κB signaling pathway could regulate the expression of MMPs [32] . To explore the underlying mechanisms of Pra-B, cells were harvested, and cytosolic and nuclear extracts were prepared. Results showed that TPA significantly increased the nuclear NF-κB-p65/-p50 expression compared with that in the control, whereas Pra-B significantly reduced this increased expression of nuclear NF- Fig. 4 . Pra-B inhibits TPA-induced AKT phosphorylation in HeLa cells. The cells were pretreated with TPA (50 ng/ml) for 2 h, incubated with Pra-B (10 and 20 μM) for 24 h, and then subjected to Western blotting to analyze the levels of p-AKT/t-AKT, p-ERK/t-ERK, p-JNK/t-JNK and p-p38/t-p38. β-actin was used as an internal control. These results are representative of three independent experiments. The values shown are the mean ± SE. **P<0.01 compared with untreated cells.
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κB-p65/-p50 (Fig. 6A ). As shown in Fig. 6B , Pra-B efficiently inhibited TPA-induced IKKα phosphorylation, whereas IKKα expression remained unchanged. In addition, Pra-B combined with LY294002 reduced the TPA-induced nuclear translocation of NF-κB-p65 and NF-κB-p50 (Fig. 6C ). These findings indicated that the NF-κB signaling pathway was involved in the inhibitory effect of Pra-B on TPA-induced AKT phosphorylation dependent on MMP-2/-9 expression in HeLa cells.
Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry In addition, mechanistic studies have reported that Pra-B inhibited MMP-2/-9 expression through IKKα/β signaling pathways and by blocking NF-κB nuclear translocation. These findings imply that the inhibition of AKT phosphorylation and the expression of NF-κB play critical roles in the inhibitory effect of Pra-B on TPA-induced migration and invasion of cervical cancer cells. Based on our major findings summarized here, we suggest that antiinvasive effects of Pra-B in play a potential role in the treatment of cervical cancer (Fig. 7) .
PI3K/AKT signaling activation is involved in cancer cell proliferation, metastasis, and angiogenesis [31, 39] . These signaling pathways have been related to the action of targeted treatments in many cancers [40, 41] . Numerous natural products have been identified as potential drugs for cancer treatment or used as anticancer adjuvants based on their ability to target multiple molecules. Recently, a natural product, fucosterol, was reported to be effective against cervical cancer based on its effect on the PI3K/Akt/mTOR cascade [42] . Another study reported that butein reduced the phosphorylation of the PI3K/AKT signaling pathway, contributing to the inhibition of cervical cancer growth and metastasis through the reduction of oxidative stress [43] . Earlier studies have revealed that AKT regulate MMP-related protein expression and cancer cell metastasis [44, 45] . Our earlier studies suggest that Pra-A reduced cell vaibility and induced cell cycle arrest at the G0/G1 phase, and Pra-A treatment inhibited the effect of TPA on ERK1/2 upregulation, MMP-2 expression, migration, and invasion in HeLa and SiHa cells [13] . However, this results different with our finding that Pra-B affects the stimulation of TPA on the expression of MMP-9/-2 at the protein and mRNA levels in HeLa cells. Although, Pra-A and Pra-B, are the major bioactive and anticancer compounds found in the Peucedanum praeruptorum Dunn, it may have different antitumor functions against human cervical cancer cells. Addition, the inhibition of MMP-2/-9 expression by Pra-B was enhanced by the co-administration of LY294002. Therefore, these results demonstrated that TPA induces migration and invasion was inhibited by Pra-B through the PI3K/AKT signaling pathway via MMP-2/-9 expression in human cervical cancer cells.
The NF-κB transcription factor was regulation of MMP-2/-9 protein expression by binding to sites on its promoter [46, 47] , and the regulation of NF-κB by PI3K/AKT is considered an important biological implication for cancer therapy [48] . A recent study reported that the suppression of NF-κB reduced TPA-induced MMP-9 expression and cell invasion in breast cancer cells [49] . PJT (Peucedanum japonicum Thunb) inhibition of cell invasion through reduction of TPA-induced MMP-9 expression and the inhibition of the PKCα/NF-κB pathway in MCF-7 cells [50] . On the basis of the aforementioned results, we investigated Pra-B antiinvasive ability of regulation NF-κB complex and found that Pra-B suppressed TPA-induced nuclear translocation of the NF-κB complex (p65, p52, and p50). Furthermore, we observed that Pra-B inhibited TPA-mediated expression of the MMP-2/-9 promoter (Fig. 6B) . These results suggested that the NF-κB complex may be involved in the inhibition of TPA-induced PI3K/AKT-mediated MMP-2/-9 expression by Pra-B. In further, it is essential that additional animal models studies in relevant cell culture models of human cervical cancer cells be undertaken to establish the anti-invasive efficacy of Pra-B and suggest if it acts via similar molecular mechanisms.
Conclusion
In this study showed that Pra-B inhibited TPA-induced migration and invasion of human cervical cancer cells. We also found that the NF-κB complex may be involved in the inhibition of TPA-induced AKT-mediated MMP-2/-9 expression by Pra-B. These results suggest that Pra-B can be a potential anti-invasive agent against cervical cancer.
